The approval of ELREXFIO (elranatamab-bcmm) is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study EL...
- Achieves $1 billion investment goal with diverse-owned suppliers Expanding diverse-owned supplier spend globally to increase impact BMS established...
"Since our founding nearly 150 years ago, we've strived to make life better for people around the world – but we know that to achieve this goal, we h...
Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic enginee...
Within3 announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The com...
Moitreyee Chatterjee-Kishore, PhD, MBA, Senior Vice President and Head of Immuno-Oncology Development, Astellas"China accounts for nearly half of...
Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...
India based biopharmaceutical firm Bharat Serums and Vaccines has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a world leader in Audit and Certificati...
The partners continue working closely on matters concerning pending approval in the U.S. for AVT02, an interchangeable high-concentration biosimilar candid...
The CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected by the end of Se...
PromoExQ MSC Growth Medium XF enables the long-term expansion of a variety of MSC types, including MSCs from the bone marrow, umbilical cord matrix, and ad...
Corning Incorporated and Laurus Labs recently celebrated the installation of Corning® Advanced-Flow™ Reactors (AFR) G4 unit a...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the expansion of its digital PCR (dPCR) offering for the development of cell and gene th...
© 2025 Biopharma Boardroom. All Rights Reserved.
